160 related articles for article (PubMed ID: 19649566)
1. Aryl-hydrocarbon receptor-dependent alteration of FAK/RhoA in the inhibition of HUVEC motility by 3-methylcholanthrene.
Chang CC; Tsai SY; Lin H; Li HF; Lee YH; Chou Y; Jen CY; Juan SH
Cell Mol Life Sci; 2009 Oct; 66(19):3193-205. PubMed ID: 19649566
[TBL] [Abstract][Full Text] [Related]
2. Mediating effects of aryl-hydrocarbon receptor and RhoA in altering brain vascular integrity: the therapeutic potential of statins.
Chang CC; Lee PS; Chou Y; Hwang LL; Juan SH
Am J Pathol; 2012 Jul; 181(1):211-21. PubMed ID: 22720799
[TBL] [Abstract][Full Text] [Related]
3. RhoA-mediated inhibition of vascular endothelial cell mobility: positive feedback through reduced cytosolic p21 and p27.
Hsu YH; Chang CC; Yang NJ; Lee YH; Juan SH
J Cell Physiol; 2014 Oct; 229(10):1455-65. PubMed ID: 24535918
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of p21 and p27 induction by 3-methylcholanthrene, an aryl-hydrocarbon receptor agonist, involved in antiproliferation of human umbilical vascular endothelial cells.
Pang PH; Lin YH; Lee YH; Hou HH; Hsu SP; Juan SH
J Cell Physiol; 2008 Apr; 215(1):161-71. PubMed ID: 18022818
[TBL] [Abstract][Full Text] [Related]
5. 3-Methylcholanthrene, an AhR agonist, caused cell-cycle arrest by histone deacetylation through a RhoA-dependent recruitment of HDAC1 and pRb2 to E2F1 complex.
Chang CC; Sue YM; Yang NJ; Lee YH; Juan SH
PLoS One; 2014; 9(3):e92793. PubMed ID: 24658119
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative and antiangiogenic effects of 3-methylcholanthrene, an aryl-hydrocarbon receptor agonist, in human umbilical vascular endothelial cells.
Juan SH; Lee JL; Ho PY; Lee YH; Lee WS
Eur J Pharmacol; 2006 Jan; 530(1-2):1-8. PubMed ID: 16359657
[TBL] [Abstract][Full Text] [Related]
7. Suppression of RhoA activity by focal adhesion kinase-induced activation of p190RhoGAP: role in regulation of endothelial permeability.
Holinstat M; Knezevic N; Broman M; Samarel AM; Malik AB; Mehta D
J Biol Chem; 2006 Jan; 281(4):2296-305. PubMed ID: 16308318
[TBL] [Abstract][Full Text] [Related]
8. 3-Methylcholanthrene and other aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha.
Abdelrahim M; Ariazi E; Kim K; Khan S; Barhoumi R; Burghardt R; Liu S; Hill D; Finnell R; Wlodarczyk B; Jordan VC; Safe S
Cancer Res; 2006 Feb; 66(4):2459-67. PubMed ID: 16489053
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin reduces the carcinogenic effect of 3-methylcholanthrene in renal epithelial cells through histone deacetylase 1 inhibition and RhoA reactivation.
Chang CC; Huang KH; Hsu SP; Lee YG; Sue YM; Juan SH
Sci Rep; 2019 Mar; 9(1):4606. PubMed ID: 30872677
[TBL] [Abstract][Full Text] [Related]
10. 3-Methylcholanthrene/Aryl-Hydrocarbon Receptor-Mediated Hypertension Through eNOS Inactivation.
Chang CC; Hsu YH; Chou HC; Lee YG; Juan SH
J Cell Physiol; 2017 May; 232(5):1020-1029. PubMed ID: 27442426
[TBL] [Abstract][Full Text] [Related]
11. GIT1 mediates thrombin signaling in endothelial cells: role in turnover of RhoA-type focal adhesions.
van Nieuw Amerongen GP; Natarajan K; Yin G; Hoefen RJ; Osawa M; Haendeler J; Ridley AJ; Fujiwara K; van Hinsbergh VW; Berk BC
Circ Res; 2004 Apr; 94(8):1041-9. PubMed ID: 15016733
[TBL] [Abstract][Full Text] [Related]
12. 3-methylcholanthrene induces differential recruitment of aryl hydrocarbon receptor to human promoters.
Pansoy A; Ahmed S; Valen E; Sandelin A; Matthews J
Toxicol Sci; 2010 Sep; 117(1):90-100. PubMed ID: 20348232
[TBL] [Abstract][Full Text] [Related]
13. 3-methylcholanthrene induces differential recruitment of aryl hydrocarbon receptor to human promoters.
Safe S
Toxicol Sci; 2010 Sep; 117(1):1-3. PubMed ID: 20651249
[TBL] [Abstract][Full Text] [Related]
14. The antiangiogenic effect of digitoxin is dependent on a ROS-elicited RhoA/ROCK pathway activation.
Boscaro C; Schimdt G; Cignarella A; Dal Maso L; Bolego C; Trevisi L
Biochem Pharmacol; 2024 Apr; 222():116049. PubMed ID: 38342347
[TBL] [Abstract][Full Text] [Related]
15. Folic acid inhibits endothelial cell migration through inhibiting the RhoA activity mediated by activating the folic acid receptor/cSrc/p190RhoGAP-signaling pathway.
Hou TC; Lin JJ; Wen HC; Chen LC; Hsu SP; Lee WS
Biochem Pharmacol; 2013 Feb; 85(3):376-84. PubMed ID: 23178654
[TBL] [Abstract][Full Text] [Related]
16. Aryl hydrocarbon receptor-independent activation of estrogen receptor-dependent transcription by 3-methylcholanthrene.
Shipley JM; Waxman DJ
Toxicol Appl Pharmacol; 2006 Jun; 213(2):87-97. PubMed ID: 16257430
[TBL] [Abstract][Full Text] [Related]
17. PyK2 and FAK connections to p190Rho guanine nucleotide exchange factor regulate RhoA activity, focal adhesion formation, and cell motility.
Lim Y; Lim ST; Tomar A; Gardel M; Bernard-Trifilo JA; Chen XL; Uryu SA; Canete-Soler R; Zhai J; Lin H; Schlaepfer WW; Nalbant P; Bokoch G; Ilic D; Waterman-Storer C; Schlaepfer DD
J Cell Biol; 2008 Jan; 180(1):187-203. PubMed ID: 18195107
[TBL] [Abstract][Full Text] [Related]
18. Activation of the aryl hydrocarbon receptor by 3-methylcholanthrene, but not by indirubin, suppresses mammosphere formation via downregulation of CDC20 expression in breast cancer cells.
Yamashita N; Yoshizuka A; Kase A; Ozawa M; Taga C; Sanada N; Kanno Y; Nemoto K; Kizu R
Biochem Biophys Res Commun; 2021 Sep; 570():131-136. PubMed ID: 34280616
[TBL] [Abstract][Full Text] [Related]
19. 3,3'-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE
Zhu P; Yu H; Zhou K; Bai Y; Qi R; Zhang S
J Exp Clin Cancer Res; 2020 Jun; 39(1):113. PubMed ID: 32546278
[TBL] [Abstract][Full Text] [Related]
20. Zoledronate inhibits endothelial cell adhesion, migration and survival through the suppression of multiple, prenylation-dependent signaling pathways.
Hasmim M; Bieler G; Rüegg C
J Thromb Haemost; 2007 Jan; 5(1):166-73. PubMed ID: 17059425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
